The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Elston George since 2016.
This trader's CIK number is 1429932.
At the time of last reporting, Elston George was the Chief Financial Officer of Eyepoint Pharmaceuticals, Inc.. (stock ticker symbol EYPT).
Also see all insider trading activities at Eyepoint Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2016 | JNP | 1,000 | $5,500 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | EYPT | 0 | $0 | 0 | $0 | 43,619 | $0 |
2024 | EYPT | 0 | $0 | 0 | $0 | 26,085 | $0 |
2023 | EYPT | 0 | $0 | 0 | $0 | 10,800 | $0 |
2020 | EYPT | 30,000 | $20,510 | 0 | $0 | 0 | $0 |
2019 | EYPT | 10,000 | $14,290 | 0 | $0 | 0 | $0 |
1. Juniper Pharmaceuticals Inc (JNP)
2. Eyepoint Pharmaceuticals, Inc. (EYPT)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2016-08-31 | JNP | Buy | 1,000 | 5.50 | 5,500 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-05-25 | EYPT | Option Ex | 7,500 | .00 | 0 |
2025-02-09 | EYPT | Option Ex | 5,834 | .00 | 0 |
2025-01-05 | EYPT | Option Ex | 15,000 | .00 | 0 |
2025-01-06 | EYPT | Option Ex | 15,285 | .00 | 0 |
2024-02-09 | EYPT | Option Ex | 10,800 | .00 | 0 |
2024-01-06 | EYPT | Option Ex | 15,285 | .00 | 0 |
2023-02-09 | EYPT | Option Ex | 10,800 | .00 | 0 |
2020-09-04 | EYPT | Buy | 10,000 | .48 | 4,800 |
2020-08-24 | EYPT | Buy | 10,000 | .61 | 6,110 |
2020-03-12 | EYPT | Buy | 10,000 | .96 | 9,600 |
2019-11-15 | EYPT | Buy | 10,000 | 1.43 | 14,290 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Elston George (Chief Financial Officer of Eyepoint Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.